NOVO.B.DK

305.1

-3.1%↓

GMAB.DK

1,963

0%↓

HLUNB.DK

43.94

-0.41%↓

ZEAL.DK

522.4

-4.91%↓

NOVO.B.DK

305.1

-3.1%↓

GMAB.DK

1,963

0%↓

HLUNB.DK

43.94

-0.41%↓

ZEAL.DK

522.4

-4.91%↓

NOVO.B.DK

305.1

-3.1%↓

GMAB.DK

1,963

0%↓

HLUNB.DK

43.94

-0.41%↓

ZEAL.DK

522.4

-4.91%↓

NOVO.B.DK

305.1

-3.1%↓

GMAB.DK

1,963

0%↓

HLUNB.DK

43.94

-0.41%↓

ZEAL.DK

522.4

-4.91%↓

NOVO.B.DK

305.1

-3.1%↓

GMAB.DK

1,963

0%↓

HLUNB.DK

43.94

-0.41%↓

ZEAL.DK

522.4

-4.91%↓

Search

Coloplast A-S (Class B)

Fermé

580.6 0.42

Résumé

Variation du prix de l'action

24h

Actuel

Min

572.4

Max

582.6

Chiffres clés

By Trading Economics

Revenu

-107M

805M

Ventes

28M

7B

P/E

Moyenne du Secteur

35.437

106.172

BPA

3.88

Rendement du dividende

4.01

Marge bénéficiaire

11.569

Employés

16,744

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

4.01%

2.31%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-8B

129B

Ouverture précédente

580.18

Clôture précédente

580.6

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

21 nov. 2025, 22:42 UTC

Market Talk

Fitch Raises Cyprus's Outlook to Positive From Stable -- Market Talk

21 nov. 2025, 21:50 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

21 nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

21 nov. 2025, 21:47 UTC

Market Talk

Mexico's 3Q GDP Prompts Growth Downgrades -- Market Talk

21 nov. 2025, 21:43 UTC

Market Talk

U.S. Crude Production Defies Low Prices, Rig Count -- Market Talk

21 nov. 2025, 20:18 UTC

Market Talk

Oil Futures Fall on U.S. Push for Russia-Ukraine Peace -- Market Talk

21 nov. 2025, 20:14 UTC

Market Talk

U.S. Natural Gas Gains As Traders Focus on Weather -- Market Talk

21 nov. 2025, 19:48 UTC

Market Talk

Precious Metals Fall for the Week -- Market Talk

21 nov. 2025, 19:44 UTC

Résultats

Deere Earnings, Inflation Data, Black Friday: What to Watch in the Next Week -- WSJ

21 nov. 2025, 19:37 UTC

Market Talk

Dollar Stalls as Stocks and Bonds Rise -- Market Talk

21 nov. 2025, 19:27 UTC

Market Talk
Résultats

Global Equities Roundup: Market Talk

21 nov. 2025, 19:27 UTC

Market Talk
Résultats

Intuit Seen With Underappreciated Credit Karma Momentum -- Market Talk

21 nov. 2025, 19:20 UTC

Market Talk

European Natural Gas Premium Versus U.S. Shrinks -- Market Talk

21 nov. 2025, 18:44 UTC

Market Talk
Acquisitions, Fusions, Rachats

Palo Alto-Chronosphere Synergies Questioned Despite M&A Record -- Market Talk

21 nov. 2025, 18:37 UTC

Market Talk

U.S. Oil Rig Count Rises By 2 to 419 -- Market Talk

21 nov. 2025, 18:34 UTC

Market Talk
Résultats

Intuit Seen Outperforming on Conservative Guidance -- Market Talk

21 nov. 2025, 18:28 UTC

Résultats

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

21 nov. 2025, 18:03 UTC

Market Talk

Mexico's Inflation Seen Up Slightly in Early November -- Market Talk

21 nov. 2025, 17:24 UTC

Market Talk

Global Equities Roundup: Market Talk

21 nov. 2025, 17:24 UTC

Market Talk

Intuit Seen on Path to Increase Growth -- Market Talk

21 nov. 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

21 nov. 2025, 17:05 UTC

Market Talk

Lowe's Getting Boost From Busy Small to Medium Pro Customer -- Market Talk

21 nov. 2025, 16:56 UTC

Market Talk

Gold Recovers as Investors Boost Rate-Cut Bets -- Market Talk

21 nov. 2025, 16:47 UTC

Market Talk

European Gas-Price Forecast to Decline Further on Expanding LNG Supply -- Market Talk

21 nov. 2025, 16:35 UTC

Acquisitions, Fusions, Rachats

What Stocks Al Gore's Investment Firm Bought and Sold This Quarter -- Barrons.com

21 nov. 2025, 16:09 UTC

Résultats

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

21 nov. 2025, 15:59 UTC

Market Talk

Canadian Consumers Tapping the Brakes, Still See Resilient -- Market Talk

21 nov. 2025, 15:59 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21 nov. 2025, 15:23 UTC

Market Talk

Bank of Canada Not Expected to Be Swayed by Canadian Retail Trade Data -- Market Talk

21 nov. 2025, 15:17 UTC

Market Talk

Canadian Consumer Spending Softening, But Could Be Worse -- Market Talk

Comparaison

Variation de prix

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat